Aurobindo Pharma Limited — JV/Acquisition, 26-09-2025: Acquisition

Aurobindo Pharma is proceeding with acquiring up to a 26% stake in Swarnaakshu Solar Power Private Limited. This strategic move aims to secure a captive solar power purchase agreement, enhancing Aurobindo's energy independence and potentially leading to operational cost savings. This backward integration step is now targeted for completion by December 31, 2025, contingent on receiving necessary state government approval. This initiative underscores Aurobindo's focus on sustainable operations and optimizing energy costs.